Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Revision: 5, Authorised

11:05 EDT 28 May 2018 | European Medicines Agency

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Revision: 5, Authorised"